Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

Roux-en-Y Gastric bypass surgery (RYGB) is emerging as a powerful tool for treatment of obesity and may also cause remission of type 2 diabetes. However, the molecular mechanism of RYGB leading to diabetes remission independent of weight loss remains elusive. In this study, we profiled plasma metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing-Run, Wang, Zi-Ming, Wewer Albrechtsen, Nicolai J., Wang, Dan-Dan, Su, Zhi-Duan, Gao, Xian-Fu, Wu, Qing-Qing, Zhang, Hui-Ping, Zhu, Li, Li, Rong-Xia, Jacobsen, SivHesse, Jørgensen, Nils Bruun, Dirksen, Carsten, Bojsen-Møller, Kirstine N., Petersen, Jacob S., Madsbad, Sten, Clausen, Trine R., Diderichsen, Børge, Chen, Luo-Nan, Holst, Jens J., Zeng, Rong, Wu, Jia-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835566/
https://www.ncbi.nlm.nih.gov/pubmed/29422288
http://dx.doi.org/10.1016/j.ebiom.2018.01.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835566/
https://www.ncbi.nlm.nih.gov/pubmed/29422288
http://dx.doi.org/10.1016/j.ebiom.2018.01.018

Ejemplares similares